The winners of a new competition to uncover innovative ideas with significant potential to become a business or social enterprise have been announced by NUI Gal...
Scientists from the Apoptosis Research Centre at NUI Galway have found that targeting the IRE1 stress response pathway may improve the response to chemotherapy ...
Dr. Diana Deca, neuroscientist, philosopher, and experienced postdoctoral neurophysiologist, joins Eternal Trusts as the chief strategy officer. Diana majored in Philosophy of Science, held positions at University of Oxford, Technical University Muni...
OncoMark Ltd (www.oncomark.com), an Irish diagnostics company, today announced the results of two key studies on the clinical performance of its OncoMasTR test....
NUI Galway will host a research seminar presented by Nobel laureate, Professor Paul Modrich of Duke University Medical Center and the Howard Hughes Medical Inst...
Austrian spin-out Valanx BioTech was founded by Michael Lukesch and Partik Fladischer and may be set to revolutionise the cancer treatment through a new targeted therapy. Over 12.7 million people worldwide discover they have cancer each year and a fu...
CATCH, the €2.1 million connected health innovative training network programme (ITN), announced today at University College Dublin (UCD) that it has finalised t...
3N Diagnostics (3NDx) has announced that its revolutionary Avisio FOXC1 immunohistochemistry (IHC) test for basal-like breast cancer (BLBC) has obtained CE Mark...
Visa has revealed that contactless payments are surging in popularity as Irish consumers are making more than three million contactless payments with Visa debit cards every week. Usage has almost tripled since the end of March 2016, with weekly trans...
